MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 422 filers reported holding MEDIVATION INC in Q2 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $152,000 | +44.8% | 2,525 | +9.9% | 0.00% | 0.0% |
| Q1 2016 | $105,000 | -16.0% | 2,297 | -10.9% | 0.00% | 0.0% |
| Q4 2015 | $125,000 | +9.6% | 2,579 | -4.1% | 0.00% | 0.0% |
| Q3 2015 | $114,000 | -36.0% | 2,688 | +72.1% | 0.00% | -33.3% |
| Q2 2015 | $178,000 | -0.6% | 1,562 | +12.7% | 0.00% | 0.0% |
| Q1 2015 | $179,000 | +27.9% | 1,386 | -1.1% | 0.00% | 0.0% |
| Q4 2014 | $140,000 | +115.4% | 1,401 | +113.6% | 0.00% | +50.0% |
| Q3 2014 | $65,000 | +132.1% | 656 | +77.8% | 0.00% | +100.0% |
| Q2 2014 | $28,000 | +7.7% | 369 | -8.7% | 0.00% | 0.0% |
| Q1 2014 | $26,000 | +30.0% | 404 | +29.9% | 0.00% | 0.0% |
| Q4 2013 | $20,000 | +150.0% | 311 | +139.2% | 0.00% | – |
| Q3 2013 | $8,000 | +14.3% | 130 | 0.0% | 0.00% | – |
| Q2 2013 | $7,000 | – | 130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $158,535,000 | 79.84% |
| Cormorant Asset Management, LP | 546,900 | $34,903,000 | 10.13% |
| BB BIOTECH AG | 1,479,706 | $94,435,000 | 5.04% |
| PFM Health Sciences, LP | 2,719,859 | $173,581,000 | 3.49% |
| Partner Investment Management, L.P. | 219,981 | $14,039,000 | 3.19% |
| Orbimed Advisors | 3,123,500 | $199,342,000 | 2.93% |
| Antipodean Advisors LLC | 525,000 | $33,506,000 | 2.90% |
| Eventide Asset Management | 134,800 | $8,603,000 | 2.65% |
| Bain Capital Public Equity Management, LLC | 1,428,117 | $91,142,000 | 2.58% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 257,055 | $16,405,000 | 2.52% |